ExodusPoint Capital Management »

Lineage Cell Therapeutics In shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $303k 182k 1.67
2025-06-30 $17k 19k 0.89
2023-03-31 $48k 32k 1.49
2021-12-31 $30k 12k 2.47
2021-03-31 $785k 334k 2.35
2020-12-31 $1.4M 808k 1.76
2020-09-30 $15k 16k 0.97
2020-06-30 $12k 13k 0.91

More positions owned by ExodusPoint Capital Management

NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Apple (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom Put Option (AVGO)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp Call Option (MDY)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Wal-Mart Stores (WMT)
Tesla Motors Put Option (TSLA)
Warner Bros Discovery Com Ser A Call Option (WBD)
Meta Platforms Cl A Call Option (META)
Electronic Arts (EA)
Evergy (EVRG)
Boeing Company (BA)

View all positions for ExodusPoint Capital Management

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Defender Capital
Raffles Associates
Brian McDonald
BlackRock
Millennium Management
Geode Capital Management
Renaissance Technologies
Goldman Sachs Group
Marshall Wace
State Street Corporation
Jane Street
Susquehanna International
Red Crane Wealth Management

View all funds holding Lineage Cell Therapeutics In